X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (619) 619
female (410) 410
male (409) 409
index medicus (330) 330
middle aged (326) 326
aged (284) 284
tetrahydroisoquinolines - therapeutic use (259) 259
adult (248) 248
tetrahydroisoquinolines - adverse effects (247) 247
tetrahydroisoquinolines (214) 214
pharmacology & pharmacy (186) 186
tetrahydroisoquinolines - administration & dosage (186) 186
treatment outcome (179) 179
solifenacin succinate (165) 165
animals (162) 162
oncology (151) 151
dioxoles - adverse effects (136) 136
trabectedin (127) 127
isoquinolines - adverse effects (121) 121
tetrahydroisoquinolines - pharmacology (112) 112
angiotensin-converting enzyme inhibitors - therapeutic use (111) 111
isoquinolines - therapeutic use (109) 109
dioxoles - therapeutic use (107) 107
quinuclidines - therapeutic use (107) 107
double-blind method (106) 106
hypertension - drug therapy (104) 104
urinary bladder, overactive - drug therapy (104) 104
angiotensin-converting enzyme inhibitors - adverse effects (98) 98
dioxoles - administration & dosage (98) 98
quinapril (94) 94
muscarinic antagonists - therapeutic use (92) 92
aged, 80 and over (90) 90
antineoplastic agents, alkylating - adverse effects (89) 89
overactive bladder (88) 88
quinuclidines - adverse effects (88) 88
antineoplastic agents, alkylating - therapeutic use (87) 87
chemotherapy (86) 86
dose-response relationship, drug (84) 84
sarcoma - drug therapy (83) 83
muscarinic antagonists - adverse effects (79) 79
cancer (78) 78
blood pressure - drug effects (74) 74
rats (70) 70
medicine & public health (66) 66
solifenacin (66) 66
tetrahydroisoquinolines - pharmacokinetics (66) 66
care and treatment (65) 65
sarcoma (65) 65
urology & nephrology (64) 64
adolescent (61) 61
prospective studies (61) 61
efficacy (60) 60
et-743 (60) 60
drug administration schedule (59) 59
young adult (59) 59
drug therapy (58) 58
drug therapy, combination (58) 58
pharmacology/toxicology (56) 56
disease-free survival (55) 55
ecteinascidin-743 (55) 55
pharmacokinetics (54) 54
hypertension (53) 53
quality of life (53) 53
analysis (52) 52
angiotensin-converting enzyme inhibitors - administration & dosage (52) 52
antineoplastic combined chemotherapy protocols - therapeutic use (51) 51
isoquinolines - administration & dosage (51) 51
tolterodine (51) 51
urinary incontinence (51) 51
mice (49) 49
quinuclidines - administration & dosage (49) 49
time factors (49) 49
muscarinic antagonists - administration & dosage (48) 48
research (48) 48
cardiac & cardiovascular systems (47) 47
therapy (47) 47
clinical trials (46) 46
antineoplastic agents, alkylating - administration & dosage (45) 45
isoquinolines - pharmacology (45) 45
safety (44) 44
ovarian neoplasms - drug therapy (41) 41
randomized controlled trials as topic (41) 41
angiotensin-converting enzyme inhibitors - pharmacology (40) 40
tolterodine tartrate (40) 40
urinary incontinence - drug therapy (40) 40
dioxoles - pharmacokinetics (39) 39
phase-ii (39) 39
soft-tissue sarcoma (39) 39
antimuscarinic agent solifenacin (38) 38
infusions, intravenous (38) 38
antihypertensive agents - therapeutic use (37) 37
administration, oral (36) 36
captopril (35) 35
trial (35) 35
antitumor-activity (34) 34
double-blind (34) 34
antihypertensive agents - adverse effects (33) 33
clinical trials as topic (33) 33
doxorubicin - administration & dosage (33) 33
hypertension - physiopathology (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (684) 684
German (14) 14
Japanese (7) 7
Russian (7) 7
Chinese (3) 3
Spanish (3) 3
Italian (2) 2
Bulgarian (1) 1
Czech (1) 1
French (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 06/2012, Volume 156, Issue 12, pp. 861 - 874
Background: Urinary incontinence (UI) in women adversely affects quality of life. Purpose: To conduct a systematic literature review of drugs for urgency UI in... 
OVERACTIVE BLADDER SYNDROME | MEDICINE, GENERAL & INTERNAL | DAILY TROSPIUM CHLORIDE | ONCE-DAILY FORMULATION | SELECTIVE RECEPTOR ANTAGONIST | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | EXTENDED-RELEASE TOLTERODINE | ANTIMUSCARINIC AGENT SOLIFENACIN | PATIENT-REPORTED OUTCOMES | Cresols - therapeutic use | Benzilates | Humans | Muscarinic Antagonists - adverse effects | Cresols - adverse effects | Solifenacin Succinate | Pyrrolidines - adverse effects | Muscarinic Antagonists - therapeutic use | Phenylpropanolamine - adverse effects | Phenylpropanolamine - therapeutic use | Pyrrolidines - therapeutic use | Benzhydryl Compounds - adverse effects | Comparative Effectiveness Research | Quinuclidines - therapeutic use | Nortropanes - adverse effects | Mandelic Acids - therapeutic use | Tolterodine Tartrate | Female | Nortropanes - therapeutic use | Mandelic Acids - adverse effects | Benzhydryl Compounds - therapeutic use | Quinuclidines - adverse effects | Benzofurans - therapeutic use | Tetrahydroisoquinolines - adverse effects | Tetrahydroisoquinolines - therapeutic use | Benzofurans - adverse effects | Randomized Controlled Trials as Topic | Urinary Incontinence - drug therapy | Quality of Life | Urinary incontinence | Research | Demographic aspects | Drug therapy | Patient outcomes
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 1, Issue 1, p. CD005429
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2015, Volume 26, Issue 5, pp. 914 - 920
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3107 - 3114
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 3, pp. 398 - 407
Abstract Background Storage symptoms are often undertreated in men with lower urinary tract symptoms (LUTS). Objective To evaluate the combination of an... 
Urology | Storage symptoms | Overactive bladder | Voiding symptoms | Solifenacin | Tamsulosin OCAS | Lower urinary tract symptoms | OCAS | Tamsulosin | TRIAL | URGENCY | PERCEPTION | UROLOGY & NEPHROLOGY | BLADDER OUTLET OBSTRUCTION | RELIABILITY | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Solifenacin Succinate | Urination Disorders - physiopathology | Urodynamics - drug effects | Male | Quinuclidines - administration & dosage | Adrenergic alpha-1 Receptor Antagonists - administration & dosage | Dose-Response Relationship, Drug | Drug Dosage Calculations | Urological Agents - adverse effects | Lower Urinary Tract Symptoms - drug therapy | Time Factors | Urination - drug effects | Adrenergic alpha-1 Receptor Antagonists - adverse effects | Urological Agents - administration & dosage | Drug Therapy, Combination | Quinuclidines - adverse effects | Urination Disorders - diagnosis | Double-Blind Method | Europe | Urination Disorders - drug therapy | Lower Urinary Tract Symptoms - physiopathology | Treatment Outcome | Tetrahydroisoquinolines - administration & dosage | Tetrahydroisoquinolines - adverse effects | Muscarinic Antagonists - administration & dosage | Lower Urinary Tract Symptoms - diagnosis | Quality of Life | Sulfonamides - adverse effects | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged | Sulfonamides - administration & dosage | Tamsulosin hydrochloride
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 6, pp. 1137 - 1147
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 19, pp. 1803 - 1813
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2011, Volume 108, Issue 2, pp. 294 - 301
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 63, Issue 1, pp. 158 - 165
Journal Article